STAT+: Tau in the spotlight at Alzheimer’s conference
From STAT's AAIC in 30 newsletter: Researchers focus on tau, and progress on crossing the blood-brain barrier.
Read the full articleYou might also wanna read
Blood Tests for Alzheimer's Disease Are Showing Promise
New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of just amyloid.
https://doi.org/10.1126/science.aeb6987
Blood biomarker pinpoints when Alzheimer's shift from amyloid to tau occurs—with precision, improving early intervention prospects. PMID:420
New Alzheimer’s Breakthrough Targets Disease at the Cellular Level, Shows Promise
A Boston biotech firm has unveiled a first-of-its-kind treatment targeting the root causes of Alzheimer’s using brain organoids, Tau biomark
New Biomarker Approach Maps Preclinical Alzheimer’s Disease Risk
Combined tau biomarkers track early cognitive decline and forecast structural neurodegeneration in preclinical Alzheimer's disease. The post
AAIC: Biogen bolsters hopes for Alzheimer's pivotal push as anti-tau oligo slows cognitive decline
Biogen's leading tau-targeting candidate has slowed cognitive decline across a suite of different clinical assessments, backing up the pharm
Biogen's experimental Alzheimer's drug diranersen reduces tau tangles and shows modest cognitive benefit in clinical trial
Clinical trial results show an experimental drug lowered tau levels in the brain and slowed some memory loss, but the data came with a surpr
Science News·1d agoBiogen's experimental Alzheimer's drug diranersen reduces tau tangles and shows modest cognitive benefit in clinical trial
Clinical trial results show an experimental drug lowered tau levels in the brain and slowed some memory loss, but the data came with a surpr
sciencenews.org·1d agoBiogen's experimental Alzheimer's drug diranersen reduces tau tangles and shows modest cognitive benefit in clinical trial
Clinical trial results show an experimental drug lowered tau levels in the brain and slowed some memory loss, but the data came with a surpr
sciencenews.org·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.